Adamantyl-pyrazole carboxamides as inhibitors of 11β-hdroxysteroid dehydrogenase
申请人:Hoffmann-La Roche Inc.
公开号:US07728029B2
公开(公告)日:2010-06-01
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
Design, synthesis and RON receptor tyrosine kinase inhibitory activity of new head groups analogs of LCRF-0004
作者:Franck Raeppel、Stéphane L. Raeppel、Eric Therrien
DOI:10.1016/j.bmcl.2015.07.080
日期:2015.9
New heteroarylcarboxamide head groups substituted with two aromatic rings analogs of thieno[3,2-b] pyridine-based kinase inhibitor LCRF-0004 were designed and synthesized. Potent inhibitors of RON tyrosine kinase with various level of selectivity for c-Met RTK were obtained. (C) 2015 Elsevier Ltd. All rights reserved.
Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase
申请人:Anderson Kevin William
公开号:US20070225280A1
公开(公告)日:2007-09-27
Provided herein are compounds of the formula (I):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.